Clinical Trials
179 trialsTIBET
Borstkanker Onderzoek Groep
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Follow-up in Early and Locally Advanced Breast Cancer Patients
European Organisation for Research and Treatment of Cancer - EORTC
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Canadian Cancer Trials Group
The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Cancer Trials Ireland
Letrozole After Tamoxifen in Treating Women With Breast Cancer
Canadian Cancer Trials Group
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Canadian Cancer Trials Group
PREcoopERA
ETOP IBCSG Partners Foundation
SOFT
ETOP IBCSG Partners Foundation
TEXT
ETOP IBCSG Partners Foundation
TEXT-Bone
ETOP IBCSG Partners Foundation
Circulating miRNAs.
Cancer Trials Ireland
Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer
Cancer Trials Ireland
TH V THL
Cancer Trials Ireland
TOUCH
ETOP IBCSG Partners Foundation
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Radiation Therapy Oncology Group
POSYTIVE
Austrian Breast & Colorectal Cancer Study Group
ACRIN6698
American College of Radiology Imaging Network
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
NSABP Foundation Inc
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Austrian Breast & Colorectal Cancer Study Group
Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
LAPATAM
European Organisation for Research and Treatment of Cancer - EORTC
PYTHIA
ETOP IBCSG Partners Foundation
METEORA-II
ETOP IBCSG Partners Foundation
Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Canadian Cancer Trials Group
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Canadian Cancer Trials Group
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Canadian Cancer Trials Group
ExCel
Canadian Cancer Trials Group
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
Canadian Cancer Trials Group
Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
Canadian Cancer Trials Group
Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer
Canadian Cancer Trials Group
OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
Canadian Cancer Trials Group
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Canadian Cancer Trials Group
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3
Canadian Cancer Trials Group
Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
Canadian Cancer Trials Group
IND197
Canadian Cancer Trials Group
A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
Canadian Cancer Trials Group
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
Canadian Cancer Trials Group
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Austrian Breast & Colorectal Cancer Study Group
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Eastern Cooperative Oncology Group
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Eastern Cooperative Oncology Group
Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer
Eastern Cooperative Oncology Group
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Eastern Cooperative Oncology Group
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
Eastern Cooperative Oncology Group
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Eastern Cooperative Oncology Group
Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy
Eastern Cooperative Oncology Group
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
Eastern Cooperative Oncology Group
Combination Chemotherapy in Treating Women With Breast Cancer
Eastern Cooperative Oncology Group
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Eastern Cooperative Oncology Group
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Eastern Cooperative Oncology Group